Related Experiment Video
Updated: Jun 6, 2026
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
A biomarker-guided therapeutic map for alopecia: in vivo evidence and clinical implications
Adniana Nareswari1,2,3, Didik Gunawan Tamtomo2, Harijono Kariosentono1,2
1Department of Dermatology and Venereology, Faculty of Medicine, Dr. Moewardi General Hospital, Sebelas Maret University, Central Java, Indonesia.
Abstract:
Alopecia is a multifactorial disorder involving disruption of immune, oxidative, apoptotic, and regenerative pathways in the hair follicle microenvironment. Despite therapeutic advances, clinical responses remain inconsistent, partly due to the limited understanding of underlying molecular targets. Integrating biomarker data may help clarify disease mechanisms and guide more targeted interventions. This review synthesizes in vivo animal evidence on six key biomarkers-tumor necrosis factor (TNF)-α, interleukin (IL)-6, malondialdehyde (MDA), caspase-3, vascular endothelial growth factor (VEGF), and β-catenin-and integrates their therapeutic implications into a biomarker-centered framework. A systematic search identified 15 animal studies (2014-2024) evaluating these biomarkers in alopecia models. TNF-α and IL-6 were generally elevated, indicating inflammation and immune-mediated follicular damage, whereas MDA reflected oxidative stress and caspase-3 activation marked apoptosis-driven regression. In contrast, VEGF and β-catenin were suppressed in alopecia but restored by effective interventions, supporting angiogenesis and Wnt-mediated regeneration. Various therapeutic approaches, including botanical extracts, bioactive compounds, sustained-release finasteride, microneedling, and nanoparticle-based delivery systems, were shown to reduce destructive biomarkers while enhancing regenerative pathways. Overall, alopecia can be conceptualized as an imbalance between degenerative and regenerative mechanisms, and a biomarker-guided therapeutic map may provide a useful translational framework for developing more precise and multitargeted treatment strategies.
Insights
Alopecia involves immune, oxidative, and regenerative pathway disruptions. This review maps key biomarkers like TNF-α and VEGF to guide targeted alopecia treatments for better outcomes.
Area of Science:
- Hair follicle biology
- Dermatology
- Molecular medicine
Background:
- Alopecia involves complex immune, oxidative, apoptotic, and regenerative pathway disruptions.
- Current alopecia treatments show inconsistent clinical responses due to limited understanding of molecular targets.
- Biomarker integration is crucial for clarifying alopecia mechanisms and guiding targeted interventions.
Purpose of the Study:
- To synthesize in vivo animal evidence on six key alopecia biomarkers: TNF-α, IL-6, MDA, caspase-3, VEGF, and β-catenin.
- To integrate biomarker data into a framework for understanding alopecia pathogenesis and therapeutic implications.
- To explore how various therapeutic strategies impact these biomarkers in alopecia models.
Main Methods:
- Systematic literature search of animal studies (2014-2024) focusing on the six selected biomarkers in alopecia models.
- Analysis of biomarker levels (elevated inflammatory/apoptotic markers, suppressed regenerative markers) in alopecia.
- Evaluation of therapeutic interventions' effects on these biomarkers.
Main Results:
- Tumor necrosis factor-α (TNF-α) and interleukin (IL)-6 were elevated, indicating inflammation and immune-mediated damage.
- Malondialdehyde (MDA) indicated oxidative stress, and caspase-3 activation marked apoptosis-driven follicular regression.
- Vascular endothelial growth factor (VEGF) and β-catenin were suppressed but restored by effective treatments, supporting angiogenesis and regeneration.
- Therapies including botanical extracts, finasteride, microneedling, and nanoparticles modulated biomarkers, reducing destructive and enhancing regenerative pathways.
Conclusions:
- Alopecia represents an imbalance between degenerative and regenerative mechanisms within the hair follicle.
- A biomarker-centered framework provides a translational map for developing precise, multitargeted alopecia treatments.
- Understanding biomarker dynamics is key to advancing alopecia therapeutic strategies.
